Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study
- PMID: 29076000
- PMCID: PMC5698203
- DOI: 10.1007/s13555-017-0204-3
Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study
Abstract
Introduction: Plaque psoriasis is a chronic skin disease where genital involvement is relatively common. Yet health care providers do not routinely evaluate psoriasis patients for genital involvement and patients do not readily initiate discussion of it.
Methods: A qualitative study of 20 US patients with dermatologist-confirmed genital psoriasis (GenPs) and self-reported moderate-to-severe GenPs at screening was conducted to identify key GenPs symptoms and their impacts on health-related quality of life (HRQoL).
Results: Patients had a mean age of 45 years, 55% were female, and patients had high rates of current/recent moderate-to-severe overall (65%) and genital (70%) psoriasis. Patients reported the following GenPs symptoms: genital itch (100%), discomfort (100%), redness (95%), stinging/burning (95%), pain (85%), and scaling (75%). Genital itching (40%) and stinging/burning (40%) were the most bothersome symptoms. Impacts on sexual health included impaired sexual experience during sexual activity (80%), worsening of symptoms after sexual activity (80%), decreased frequency of sexual activity (80%), avoidance of sexual relationships (75%), and reduced sexual desire (55%). Negative effects on sexual experience encompassed physical effects such as mechanical friction, cracking, and pain as well as psychosocial effects such as embarrassment and feeling stigmatized. Males reported a higher burden of symptoms and sexual impacts. Other HRQoL impacts were on mood/emotion (95%), physical activities (70%), daily activities (60%), and relationships with friends and family (45%). These impacts significantly affected daily activities. Physical activities were affected by symptoms and flares, and increased sweat and friction worsened symptoms. Patients reported daily practices to control outcomes.
Conclusion: The high level of reported symptoms and sexual and nonsexual impacts reflects the potential burden of moderate-to-severe GenPs. GenPs can impact many facets of HRQoL and providers should evaluate their patients for the presence of genital psoriasis and its impact on their quality of life.
Funding: Eli Lilly and Company.
Keywords: Burden of illness; Genital psoriasis; Health-related quality of life; Qualitative research.
Figures


Similar articles
-
The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health.Dermatol Ther (Heidelb). 2018 Mar;8(1):33-44. doi: 10.1007/s13555-017-0212-3. Epub 2017 Dec 4. Dermatol Ther (Heidelb). 2018. PMID: 29204894 Free PMC article.
-
The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS).Dermatol Ther (Heidelb). 2018 Mar;8(1):45-56. doi: 10.1007/s13555-017-0213-2. Epub 2017 Dec 4. Dermatol Ther (Heidelb). 2018. PMID: 29204893 Free PMC article.
-
Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study.J Sex Med. 2018 Nov;15(11):1645-1652. doi: 10.1016/j.jsxm.2018.09.004. J Sex Med. 2018. PMID: 30415816 Clinical Trial.
-
Prevalence of genital psoriasis in patients with psoriasis.J Dermatolog Treat. 2018 Dec;29(8):754-760. doi: 10.1080/09546634.2018.1453125. Epub 2018 Mar 28. J Dermatolog Treat. 2018. PMID: 29565190 Review.
-
Genital Psoriasis: Impact on Quality of Life and Treatment Options.Am J Clin Dermatol. 2019 Oct;20(5):639-646. doi: 10.1007/s40257-019-00447-5. Am J Clin Dermatol. 2019. PMID: 31313079 Review.
Cited by
-
Recalcitrant anal and genital pruritus treated with dupilumab.Int J Womens Dermatol. 2018 Oct 4;4(4):223-226. doi: 10.1016/j.ijwd.2018.08.010. eCollection 2018 Dec. Int J Womens Dermatol. 2018. PMID: 30627621 Free PMC article.
-
Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G-EPOSS study.J Eur Acad Dermatol Venereol. 2025 Mar;39 Suppl 1(Suppl 1):15-26. doi: 10.1111/jdv.19927. Epub 2024 Apr 11. J Eur Acad Dermatol Venereol. 2025. PMID: 38602225 Free PMC article.
-
Benefits and Satisfaction with Apremilast Treatment in Patients with Psoriasis Affecting the Genital Area: Secondary Analysis of the APPRECIATE Study.Dermatol Ther (Heidelb). 2025 Mar;15(3):681-695. doi: 10.1007/s13555-025-01360-y. Epub 2025 Feb 19. Dermatol Ther (Heidelb). 2025. PMID: 39969771 Free PMC article.
-
Treatment of Genital Psoriasis: A Systematic Review.Dermatol Ther (Heidelb). 2018 Dec;8(4):509-525. doi: 10.1007/s13555-018-0257-y. Epub 2018 Aug 25. Dermatol Ther (Heidelb). 2018. PMID: 30145740 Free PMC article. Review.
-
Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States.Dermatol Ther (Heidelb). 2024 Jul;14(7):1839-1847. doi: 10.1007/s13555-024-01190-4. Epub 2024 Jun 14. Dermatol Ther (Heidelb). 2024. PMID: 38874893 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials